But second-line novel bispecific antibody and paclitaxel failed to improve overall surviva ...

Summit says ivonescimab beat Imfinzi in late-stage biliary tract cancer. See trial survival data, safety findings and why U.S ...

Summit Therapeutics SMMT is expanding the clinical development of its lead investigational drug, ivonescimab, beyond lung ...

Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, ...

A case report describes cholestatic liver injury during atezolizumab therapy for EGFR-mutant combined small cell lung cancer, ...

Summit Therapeutics Inc. noted that its partner Akeso Inc. announced positive results from the Phase III HARMONi-GI1 study evaluating the novel, potential first-in-class investigational bispecific ...

A new review argues that three-dimensional tumor models, including patient-derived organoids, can reveal the drug resistance ...

Nice to meet you. I run the "Anticancer Drug Encyclopedia." I am a practicing pharmacist and hold certifications and specialized qualifications in the field of oncology. In my daily work, I have heard ...

Dublin, March 30, 2026 (GLOBE NEWSWIRE)-- The "Bile Duct Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bile duct cancer market is witnessing robust growth, ...

Richard Lloyd, a founding member and guitarist of the influential rock band Television, has been diagnosed with bile-duct cancer. Lloyd, 74, was diagnosed with cholangiocarcinoma in March, according ...